Results · Apr-Jun 2026 · filed 14 Aug 2026
Fischer Medical Ventures Q1 FY27 results
Sales grew 249% to ₹81.9 crore from ₹23.4 crore in Apr-Jun 2025.
Operating profit grew 164% to ₹11.3 crore, an operating margin of 13.7% (down 4.4 points from a year ago).
Net profit fell 24% to ₹3.8 crore from ₹5 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −16%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 81.9 | 23.4 | +249% |
| Operating profit (EBITDA) | 11.3 | 4.3 | +164% |
| Operating margin | 13.7% | 18.2% | −4.4 pts |
| Net profit | 3.8 | 5.0 | −24% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 18 Aug 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- 18 Aug 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- 18 Aug 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- 17 Aug 2026Announcement under Regulation 30 (LODR)-Allotment
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Allotment
- 14 Aug 2026Financial Results For Q 1 FY 2026-27
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Resignation of Director
- 14 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.